Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases ...

Q2 2025 Earnings Call Transcript May 12, 2025 Arrowhead Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2 ...

After earning notoriety as the first cellular receptor isolated and mammalian lectin identified, the Ashwell-Morell ...

An international team of researchers has discovered how cholesterol can disrupt the internal functioning of the heart by ...